Get BRENZAVVY^® Delivered for $59⁹⁵

No, Brenzavvy is not currently available at local pharmacies. The manufacturer of Brenzavvy, TheracosBio, and Marley Drug have like-minded goals to provide broader access to drugs at a low cost. The partnership recognizes the benefits of a direct sales route from manufacturer to end user and ultimately, eliminates unnecessary expenses associated with the middleman. Because of this, Brenzavvy is not available at local pharmacies.

Unlike Brenzavvy, other branded SGLT-2 medications like Jardiance, Farxiga & Invokana have a high retail price of over $500. Marley Drug partnered directly with the manufacturer, TheracosBio, to create easy, affordable access to Brenzavvy without the hassle of insurance. TheracosBio & Marley Drug share a common goal of providing broader access to drugs at a lower cost. By partnering with the manufacturer, we are able to bypass intermediaries and reduce unnecessary expenses associated with the middleman. Both companies prioritize making medications accessible to a wide range of patients, while still fulfilling business needs.

Brenzavvy has been studied as monotherapy and in combination with metformin in adults with type 2 diabetes mellitus. Brenzavvy has also been studied in adults with type 2 diabetes mellitus with moderate renal impairment and in adults with type 2 diabetes mellitus with established cardiovascular disease or at increased risk for cardiovascular disease.

Treatment with Brenzavvy reduced hemoglobin A1C (HbA1c) compared to placebo and efficacy was noninferior to glimepiride (up-titrated to a max dose of 6mg) and sitagliptin 100 mg dose once daily. See Prescribing Information for more detail.

Brenzavvy (bexagliflozin) is manufactured by TheracosBio. TheracosBio aims to provide access to new medications for patients with common diseases. They believe that appropriate pricing will lead to more rapid advances in public health. 

Brenzavvy contains 20mg of bexagliflozin and is recommended to be taken once daily, at the beginning of the day, with or without food. Brenzavvy is not recommended for use to improve glycemis control in patients with type 1 diabetes mellitus. Testing for renal function should be conducted prior to the initiation of Brenzavvy.

Brenzavvy is an FDA approved SGLT-2 (sodium-glucose transport protein 2) that came to market in January 2023.

Although BRENZAVVY has not received FDA approval for weight loss, modest decreases in weight were observed in clinical studies. Adults with type 2 diabetes saw a reduction in body weight of 4 to 8 pounds on average after 24 weeks of treatment with BRENZAVVY 20 mg, while patients in the same studies treated with placebo saw a reduction in body weight of up to 3 pounds on average.

Although BRENZAVVY has not received FDA approval for lowering blood pressure, modest decreases in blood pressure were observed in clinical studies of adults with type 2 diabetes. The reduction of blood pressure was durable over time and measured during up to 96 weeks of treatment with BRENZAVVY 20 mg versus placebo.

BRENZAVVY (bexagliflozin) is a tablet that contains 20 mg of bexagliflozin and is recommended to be taken once daily, in the morning (or at the beginning of the day if that is not in the morning) with or without food. Take BRENZAVVY exactly as your doctor instructs.
If you are scheduled for a major surgery or procedure that requires fasting, do not take BRENZAVVY for at least 3 days prior to the surgery, if possible. Talk to your doctor about when you should resume taking BRENZAVVY following a major surgery or procedure.

The most common side effects of BRENZAVVY (bexagliflozin) include:

• vaginal yeast infections
• urinary tract infections
• increased urination

The active ingredient in Brenzavvy is bexagliflozin.

Inactive ingredients include colloidal silicon dioxide, glyceryl dibehenate, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene oxide, and poloxamer 188. In addition, the film coating ingredient, Opadry® II Blue 85F99153, contains the inactive ingredients FD&C Blue #1/Brilliant Blue FCF and FD&C Blue #2/Indigo Carmine, macrogol 3350, polyvinyl alcohol, talc, and titanium dioxide.

BRENZAVVY (bexagliflozin) can be taken with or without food.

No. BRENZAVVY (bexagliflozin) is not for people with type 1 diabetes.

BRENZAVVY (bexagliflozin) is an SGLT2 inhibitor – this class of drugs works by causing excess sugar in the blood to be released from the body through the urine, thereby lowering the blood sugar level.

Some diabetes medications are a combination of an SGLT2 inhibitor and another drug like metformin.

These medications are combined mostly for convenience. Metformin is often the first choice when treating type 2 diabetes because it works well and usually doesn't cause too many side effects. But sometimes, metformin alone isn't enough to control your blood sugar and A1C. That's when you might need another medication, like an SGLT2 inhibitor.

BRENZAVVY (bexagliflozin) is an FDA-approved prescription medicine taken once daily to help adults with type 2 diabetes improve glycemic (blood sugar) control in conjunction with diet and exercise. BRENZAVVY is not for people with type 1 diabetes.